Brighthouse Financial Reports Q4 & FY25 Earnings Amidst Pending $70/Share Acquisition

summarizeSummary

Brighthouse Financial reported a significant decline in Q4 and full-year 2025 net income and adjusted earnings, while also confirming shareholder approval for its acquisition by Aquarian Holdings for $70.00 per share.

check_boxKey Events

• Q4 2025 Financial Results Decline

  Net income available to shareholders was $112 million ($1.93 per diluted share), a significant decrease from $646 million ($10.79 per diluted share) in Q4 2024. Adjusted earnings, less notable items, were $227 million ($3.93 per diluted share), down from $352 million ($5.88 per diluted share) in the prior year quarter.

• Full Year 2025 Adjusted Earnings Decrease

  Full year adjusted earnings, less notable items, decreased to $931 million ($16.07 per diluted share) in 2025 from $1,209 million ($19.63 per diluted share) in 2024.

• Strong Capital Position Maintained

  The company reported a preliminary combined risk-based capital (RBC) ratio of 456%, exceeding its target range of 400% to 450%.

• Sales Growth in Annuities and Life Insurance

  Full year 2025 annuity sales increased 3% year-over-year to $10.3 billion, driven by record Shield Level Annuities sales. Life sales reached a record $143 million, up 19% year-over-year.

auto_awesomeAnalysis

This filing provides Brighthouse Financial's fourth quarter and full year 2025 financial results, which show a notable decline in net income and adjusted earnings compared to the prior year. This information is significant as it offers insight into the company's performance leading up to its pending acquisition by Aquarian Holdings for $70.00 per share. While operational sales for annuities and life insurance showed growth, the overall profitability metrics declined. The company maintains a strong capital position with an RBC ratio of 456%, which is a positive indicator of financial stability. The reiteration of shareholder approval for the merger, which occurred on February 12, 2026, confirms the transaction is progressing towards its expected 2026 close, subject to regulatory approvals. Investors should monitor the closing conditions and any further updates regarding the acquisition, as the current stock price of $62.54 remains below the offer price.